Published in Lipids on September 22, 2017
Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities. Drug Metab Dispos (1991) 2.51
Relationship of uric acid with progression of kidney disease. Am J Kidney Dis (2007) 2.26
Tissue sites of degradation of apoprotein A-I in the rat. J Biol Chem (1983) 1.77
Role of oxidative stress in the renal abnormalities induced by experimental hyperuricemia. Am J Physiol Renal Physiol (2008) 1.68
Uric acid levels are associated with all-cause and cardiovascular disease mortality independent of systemic inflammation in men from the general population: the MONICA/KORA cohort study. Arterioscler Thromb Vasc Biol (2008) 1.55
Uremia alters HDL composition and function. J Am Soc Nephrol (2011) 1.55
Hyperuricemia causes glomerular hypertrophy in the rat. Am J Nephrol (2002) 1.39
Enzymatically active paraoxonase-1 is located at the external membrane of producing cells and released by a high affinity, saturable, desorption mechanism. J Biol Chem (2001) 1.39
Oxidative stress and hyperuricaemia: pathophysiology, clinical relevance, and therapeutic implications in chronic heart failure. Eur J Heart Fail (2009) 1.17
Uric acid predicts clinical outcomes in heart failure: insights regarding the role of xanthine oxidase and uric acid in disease pathophysiology. Circulation (2003) 1.12
HDL stimulation of endothelial nitric oxide synthase: a novel mechanism of HDL action. Trends Cardiovasc Med (2003) 1.02
Epidemiological association between uric acid concentration in plasma, lipoprotein(a), and the traditional lipid profile. Clin Cardiol (2010) 0.98
Uric acid concentration as a risk marker for blood pressure progression and incident hypertension: a Chinese cohort study. Metabolism (2012) 0.97
High-density lipoprotein apolipoprotein A-I kinetics in obese insulin resistant patients. An in vivo stable isotope study. Int J Obes Relat Metab Disord (2002) 0.97
Synergistic effect of uricase blockade plus physiological amounts of fructose-glucose on glomerular hypertension and oxidative stress in rats. Am J Physiol Renal Physiol (2013) 0.93
Effect of the treatment with allopurinol on the endothelial function in patients with hyperuricemia. Endocr Res (2011) 0.91
Uric acid induces fat accumulation via generation of endoplasmic reticulum stress and SREBP-1c activation in hepatocytes. Lab Invest (2014) 0.90
Uric acid and prognosis in angiography-proven coronary artery disease. Eur J Clin Invest (2012) 0.90
Lipoprotein subfractions partly mediate the association between serum uric acid and coronary artery disease. Clin Chim Acta (2014) 0.88
Genomic evidence for the absence of a functional cholesteryl ester transfer protein gene in mice and rats. Comp Biochem Physiol B Biochem Mol Biol (2003) 0.87
The function, composition, and particle size of high-density lipoprotein were severely impaired in an oliguric phase of hemorrhagic fever with renal syndrome patients. Clin Biochem (2007) 0.85
Chronic sildenafil treatment corrects endothelial dysfunction and improves hypertension. Am J Nephrol (2010) 0.83
Serum uric acid as an independent predictor of mortality in high-risk patients with obstructive coronary artery disease: a prospective observational cohort study from the ET-CHD registry, 1997-2003. J Cardiol (2012) 0.82
HDL-cholesterol in coronary artery disease risk: function or structure? Clin Chim Acta (2013) 0.80
Lipid plasma concentrations of HDL subclasses determined by enzymatic staining on polyacrylamide electrophoresis gels in children with metabolic syndrome. Clin Chim Acta (2010) 0.79
Clearance of postprandial and lipolytically modified human HDL in rabbits and rats. J Lipid Res (1997) 0.79
Effect of atorvastatin on high-density lipoprotein apolipoprotein A-I production and clearance in the New Zealand white rabbit. Circulation (2002) 0.79
Regulation of endothelial lipase and systemic HDL cholesterol levels by SREBPs and VEGF-A. Atherosclerosis (2012) 0.79
Shift of high-density lipoprotein size distribution toward large particles in patients with proteinuria. Clin Chim Acta (2012) 0.79
Association of uric acid with mortality in patients with stable coronary artery disease. Metabolism (2012) 0.78
Contribution of cholesteryl ester transfer protein and lecithin:cholesterol acyltransferase to HDL size distribution. Endocr Res (2004) 0.78
High-density lipoprotein endocytosis in endothelial cells. World J Biol Chem (2013) 0.78
Pioglitazone increases the fractional catabolic and production rates of high-density lipoproteins apo AI in the New Zealand White Rabbit. Atherosclerosis (2005) 0.78
Early endothelial nitrosylation and increased abdominal adiposity in Wistar rats after long-term consumption of food fried in canola oil. Nutrition (2014) 0.78
Hyperalphalipoproteinemia in human lecithin cholesterol acyltransferase transgenic rabbits. In vivo apolipoprotein A-I catabolism is delayed in a gene dose-dependent manner. J Clin Invest (1996) 0.78
Increased HDL Size and Enhanced Apo A-I Catabolic Rates Are Associated With Doxorubicin-Induced Proteinuria in New Zealand White Rabbits. Lipids (2016) 0.77
Normal HDL-apo AI turnover and cholesterol enrichment of HDL subclasses in New Zealand rabbits with partial nephrectomy. Metabolism (2012) 0.77
Effects of oxonic acid-induced hyperuricemia on mesenteric artery tone and cardiac load in experimental renal insufficiency. BMC Nephrol (2015) 0.76
Serum uric acid level as a determinant of the metabolic syndrome: A case control study. Diabetes Metab Syndr (2016) 0.76
Hypoxanthine induces cholesterol accumulation and incites atherosclerosis in apolipoprotein E-deficient mice and cells. J Cell Mol Med (2016) 0.76
Enzymatic assessment of cholesterol on electrophoresis gels for estimating HDL size distribution and plasma concentrations of HDL subclasses. J Lipid Res (2010) 0.76
The Establishment and Characteristics of Rat Model of Atherosclerosis Induced by Hyperuricemia. Stem Cells Int (2015) 0.76